Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

SEC Filing Details

Document Details

Form
Filing Date
Jul 11, 2013
Document Date
Jul 11, 2013
Form Description
Amended Registration statement for face-amount certificate companies
Filing Group
Registration Statements
Company
Agios Pharmaceuticals, Inc.
Issuer
AGIOS PHARMACEUTICALS INC